METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway

Abstract Hepatic fibrosis (HF) is caused by chronic hepatic injury and is characterized by hepatic stellate cells (HSCs) activation. Studies focusing on the function of exosomes derived from macrophages in HF progression are limited. This study aims to identify the roles of exosomal NEAT1 derived fr...

Full description

Bibliographic Details
Main Authors: Bo Shu, Rui-Zhi Zhang, Ying-Xia Zhou, Chao He, Xin Yang
Format: Article
Language:English
Published: Nature Publishing Group 2022-05-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-022-01036-y
_version_ 1811341367245275136
author Bo Shu
Rui-Zhi Zhang
Ying-Xia Zhou
Chao He
Xin Yang
author_facet Bo Shu
Rui-Zhi Zhang
Ying-Xia Zhou
Chao He
Xin Yang
author_sort Bo Shu
collection DOAJ
description Abstract Hepatic fibrosis (HF) is caused by chronic hepatic injury and is characterized by hepatic stellate cells (HSCs) activation. Studies focusing on the function of exosomes derived from macrophages in HF progression are limited. This study aims to identify the roles of exosomal NEAT1 derived from macrophages on HF and the underlying mechanisms. Our studies showed that METTL3 targeted and enhanced NEAT1 expression in macrophages. Exosomal NEAT1 originating from LPS-treated macrophages promoted HSCs proliferation and migration, and induced the expression of fibrotic proteins including collagen I, α-SMA, and fibronectin. Macrophage exosomal NEAT1 contributed to HSCs activation by sponging miR-342. MiR-342 directly targeted Sp1 and suppressed its downstream TGF-β1/Smad signaling pathway, which eventually led to the inhibition of HSCs activation. Depletion of NEAT1 in the macrophage exosomes inhibited HF progression both in vitro and in vivo. Altogether, our study proved that silence of NEAT1 in the macrophage exosomes exerted protective roles against HF through the miR-342/Sp1/TGF-β1/Smad signaling pathway, suggesting a potential therapeutic target in HF treatment.
first_indexed 2024-04-13T18:54:31Z
format Article
id doaj.art-543afb54e0a1486c91eafb609fdf29b5
institution Directory Open Access Journal
issn 2058-7716
language English
last_indexed 2024-04-13T18:54:31Z
publishDate 2022-05-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj.art-543afb54e0a1486c91eafb609fdf29b52022-12-22T02:34:18ZengNature Publishing GroupCell Death Discovery2058-77162022-05-018111410.1038/s41420-022-01036-yMETTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathwayBo Shu0Rui-Zhi Zhang1Ying-Xia Zhou2Chao He3Xin Yang4Department of General Surgery, The Second Xiangya Hospital, Central South UniversityDepartment of General Surgery, The Second Xiangya Hospital, Central South UniversityDepartment of Surgical Operation, The Second Xiangya Hospital, Central South UniversityDepartment of General Surgery, The Second Xiangya Hospital, Central South UniversityDepartment of General Surgery, The Second Xiangya Hospital, Central South UniversityAbstract Hepatic fibrosis (HF) is caused by chronic hepatic injury and is characterized by hepatic stellate cells (HSCs) activation. Studies focusing on the function of exosomes derived from macrophages in HF progression are limited. This study aims to identify the roles of exosomal NEAT1 derived from macrophages on HF and the underlying mechanisms. Our studies showed that METTL3 targeted and enhanced NEAT1 expression in macrophages. Exosomal NEAT1 originating from LPS-treated macrophages promoted HSCs proliferation and migration, and induced the expression of fibrotic proteins including collagen I, α-SMA, and fibronectin. Macrophage exosomal NEAT1 contributed to HSCs activation by sponging miR-342. MiR-342 directly targeted Sp1 and suppressed its downstream TGF-β1/Smad signaling pathway, which eventually led to the inhibition of HSCs activation. Depletion of NEAT1 in the macrophage exosomes inhibited HF progression both in vitro and in vivo. Altogether, our study proved that silence of NEAT1 in the macrophage exosomes exerted protective roles against HF through the miR-342/Sp1/TGF-β1/Smad signaling pathway, suggesting a potential therapeutic target in HF treatment.https://doi.org/10.1038/s41420-022-01036-y
spellingShingle Bo Shu
Rui-Zhi Zhang
Ying-Xia Zhou
Chao He
Xin Yang
METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway
Cell Death Discovery
title METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway
title_full METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway
title_fullStr METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway
title_full_unstemmed METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway
title_short METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway
title_sort mettl3 mediated macrophage exosomal neat1 contributes to hepatic fibrosis progression through sp1 tgf β1 smad signaling pathway
url https://doi.org/10.1038/s41420-022-01036-y
work_keys_str_mv AT boshu mettl3mediatedmacrophageexosomalneat1contributestohepaticfibrosisprogressionthroughsp1tgfb1smadsignalingpathway
AT ruizhizhang mettl3mediatedmacrophageexosomalneat1contributestohepaticfibrosisprogressionthroughsp1tgfb1smadsignalingpathway
AT yingxiazhou mettl3mediatedmacrophageexosomalneat1contributestohepaticfibrosisprogressionthroughsp1tgfb1smadsignalingpathway
AT chaohe mettl3mediatedmacrophageexosomalneat1contributestohepaticfibrosisprogressionthroughsp1tgfb1smadsignalingpathway
AT xinyang mettl3mediatedmacrophageexosomalneat1contributestohepaticfibrosisprogressionthroughsp1tgfb1smadsignalingpathway